Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Osteosarcoma 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × endostar protein × Clear all
NCT01907529 2019-08-09

TENDENCY

Hebei Medical University Fourth Hospital

Phase 2/3 Unknown
300 enrolled
Breast

Breast Neoplasms

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
50 enrolled
Breast

Breast Neoplasms

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Fujian Cancer Hospital

Phase 3 Unknown
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡